Integra LifeSciences (NASDAQ:IART) Raised to Buy at Argus
Integra LifeSciences (NASDAQ:IART – Get Free Report) was upgraded by equities research analysts at Argus from a “hold” rating to a “buy” rating in a report released on Monday, MarketBeat Ratings reports. Separately, Morgan Stanley assumed coverage on shares of Integra LifeSciences in a research report on Monday, December 2nd. They issued an “underweight” rating […]
